Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2022, Vol. 36 ›› Issue (5): 46-50.doi: 10.6040/j.issn.1673-3770.0.2021.263

Previous Articles    

Clinical efficacy of lecithin complex iodine capsule in the adjuvant treatment of retinal vein occlusion

GU Ranran1, LI Fengjiao2, JIAO Wanzhen2, CUI Yanyan1, ZHAO Bojun2   

  1. 1. First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan 250014, Shandong, China;
    2. Department of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China
  • Published:2022-09-20

PDF (PC)

146

Abstract: Objective To explore the clinical efficacy of lecithin complex iodine capsule combined with ranibizumab in the treatment of macular edema secondary to retinal vein occlusion(RVO-ME). Methods 40 patients(40 eyes)with RVO-ME who were admitted to our hospital from January 2020 to February 2021 were randomly divided into two groups: ranibizumab group and lecithin combination group, 19 cases(19 eyes)in ranibizumab group and 21 cases(21 eyes)in lecithin combination group. The patients in ranibizumab group were treated with intravitreal injection of ranibizumab every 4 weeks, and the patients in lecithin combined group were treated with lecithin complex iodine capsule combined with ranibizumab every 4 weeks, follow-up every 4 weeks during the 12 weeks observation period, The changes of intraocular pressure(IOP), best-corrected visual acuity(BCVA), fundus bleeding area, central macular thickness(CMT), fovea avascular zone(FAZ), choriocaphillaris flow area(CFA), superficial capillary plexus(SCP)and deep capillary plexus(DCP)were observed before and after treatment. Results BCVA(LogMAR)and CMT of the two groups at each treatment time point were significantly improved compared with those before treatment, and there was no significant difference between the two groups. FAZ and SCP: there was no significant difference between the two groups before and after treatment, and there was no significant difference between the two groups. Fundus hemorrhage area: the fundus hemorrhage area of the two groups at each treatment time point was significantly lower than that before treatment. The fundus hemorrhage absorption of the lecithin combined group at each treatment time point was better than that of the ranibizumab group, and the difference was statistically significant. CFA in the eyes of the two groups increased before and after teatment, the difference was statistically significant, and there was no significant difference between the two groups. After 12 weeks of follow-up, DCP in the eyes of the two groups showed a significant increase trend, the difference was statistically significant, and the improvement of DCP in lecithin combined group was better than that in leizumab group, the difference was statistically significant. Conclusions Lecithin complex iodine capsule in the adjuvant treatment of retinal vein occlusion can achieve a better result in promoting the absorption of fundus hemorrhage and increase the density of deep retinal capillaries.

Key words: Retinal Vein Occlusion, Ranibizumab, Lecithin Complex Iodine, Macular Edema

CLC Number: 

  • R774.1
[1] Daruich A, Matet A, Moulin A, et al. Mechanisms of macular edema: Beyond the surface[J]. Prog Retin Eye Res, 2018, 63: 20-68. doi:10.1016/j.preteyeres.2017.10.006.
[2] Rogers S, McIntosh RL, Cheung N, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia[J]. Ophthalmology, 2010,117(2): 313-319.e1. doi:10.1016/j.ophtha.2009.07.017.
[3] Ng DSC, Fung NSK, Yip FLT, et al. Ranibizumab for myopic choroidal neovascularization[J]. Expert Opin Biol Ther, 2020, 20(12): 1385-1393. doi:10.1080/14712598.2021.1830969.
[4] Campa C, Alivernini G, Bolletta E, et al. Anti-VEGF therapy for retinal vein occlusions[J]. Curr Drug Targets, 2016, 17(3): 328-336. doi:10.2174/1573399811666150615151324.
[5] 詹凌. 观察卵磷脂络合碘片(沃丽汀)治疗黄斑水肿的临床疗效[J]. 2016, 32(6): 887-889, 891. doi:10.3969/j.issn.1000-484X.2016.06.026. ZHAN Ling. Study on efficacy of iodized lecithin tablets in treatment of macular edema[J]. Chinese Journal of Immunology, 2016, 32(6): 887-889, 891. doi:10.3969/j.issn.1000-484X.2016.06.026.
[6] 栗洵, 陈琳琳. 激光光凝眼底联合卵磷脂络合碘片治疗中心性浆液性脉络膜视网膜病变的效果[J]. 中国医药导报, 2015, 12(36): 101-104. LI Xun, CHEN Linlin. Effect of laser photocoagulation fundus combined with Iodized Lecithin Tablets in the treatment of central serous chorioretinopathy[J]. China Medical Herald, 2015, 12(36): 101-104.
[7] Schmidt-Erfurth U, Garcia-Arumi J, Gerendas BS, et al. Guidelines for the management of retinal vein occlusion by the European society of Retina specialists(EURETINA)[J]. Ophthalmol J Intd' Ophtalmologie Int J Ophthalmol Zeitschrift Fur Augenheilkunde, 2019, 242(3): 123-162. doi:10.1159/000502041.
[8] 韩克阳, 于贝贝, 赵博军. 短期视网膜静脉阻塞抗VEGF治疗后黄斑区形态结构分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(5): 129-131. doi:10.1159/000455809.0.2017.515. HAN Keyang, YU Beibei, ZHAO Bojun. Morphological structure analysis of the macular area after anti-VEGF treatment for short-term retinal vein occlusion[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(5): 129-131.doi:10.1159/000455809.0.2017.515.
[9] Cunha-Vaz J. The blood-retinal barrier in the management of retinal disease: EURETINA award lecture[J]. Ophthalmologica, 2017, 237(1): 1-10. doi:10.1159/000455809.
[10] Cachafeiro M, Bemelmans AP, Samardzija M, et al. Hyperactivation of Retina by light in mice leads to photoreceptor cell death mediated by VEGF and retinal pigment epithelium permeability[J]. Cell Death Dis, 2013, 4: e781. doi:10.1038/cddis.2013.303.
[11] Xia JP, Wang S, Zhang JS. The anti-inflammatory and anti-oxidative effects of conbercept in treatment of macular edema secondary to retinal vein occlusion[J]. Biochem Biophys Res Commun, 2019,508(4): 1264-1270. doi:10.1016/j.bbrc.2018.12.049.
[12] Sugimoto M, Kondo M. Lecithin-bound iodine prevents disruption of tight junctions of retinal pigment epithelial cells under hypoxic stress[J]. J Ophthalmol, 2016, 2016: 9292346. doi:10.1155/2016/9292346.
[13] Lee A, Taylor P, Kalpathy-Cramer J, et al. Machine learning has arrived![J]. Ophthalmology, 2017, 124(12): 1726-1728. doi:10.1016/j.ophtha.2017.08.046.
[14] Jiang F, Jiang Y, Zhi H, et al. Artificial intelligence in healthcare: past, present and future[J]. Stroke Vasc Neurol, 2017, 2(4): 230-243. doi:10.1136/svn-2017-000101.
[15] 王丽雯, 崔林, 邹吉新, 等. OCTA在视网膜静脉阻塞诊疗中的应用价值[J]. 国际眼科杂志, 2019, 19(8): 1361-1364. doi:10.3980/j.issn.1672-5123.2019.8.22. WANG Liwen, CUI Lin, ZOU Jixin, et al. Application value of OCTA examination in diagnosis and treatment of retinal vein occlusion[J]. International Eye Science, 2019, 19(8): 1361-1364. doi:10.3980/j.issn.1672-5123.2019.8.22.
[16] Okamoto M, Yamashita M, Sakamoto T, et al. Choroidal blood flow and thickness as predictors for response to anti-vascular endothelial growth factor therapy in macular edema secondary to branch retinal vein occlusion[J]. Retina, 2018, 38(3): 550-558. doi:10.1097/IAE.0000000000001566.
[17] Lee H, Kim MA, Kim HC, et al. Characterization of microvascular tortuosity in retinal vein occlusion utilizing optical coherence tomography angiography[J]. Sci Rep, 2020, 10(1): 17788. doi:10.1038/s41598-020-74871-7.
[18] 金昕, 谭薇, 李燕. 量化OCTA在视网膜静脉阻塞中的应用[J]. 国际眼科杂志, 2021, 21(4): 711-714. doi:10.3980/j.issn.1672-5123.2021.4.30. JIN Xin, TAN Wei, LI Yan. Application of quantitative OCTA in retinal vein occlusion[J]. International Eye Science, 2021, 21(4): 711-714.doi:10.3980/j.issn.1672-5123.2021.4.30.
[1] ZHANG Taoran, WANG Wei, LI Mingming, HUANG Yingxiang. Subfoveal choroidal thickness changes following intravitreal ranibizumab treatment in choroidal neovascularization due to pathological myopia [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 68-71.
[2] Keyang HAN,Beibei YU,Bojun ZHAO. Morphological structure analysis of the macular area after anti-VEGF treatment for short-term retinal vein occlusion [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(5): 129-131.
[3] LIU Jianbo, ZHANG Huan. Phacoemulsification combined with intravitreal ranibizumab or triamcinolone acetonide injection for the treatment of cataract accompanied by diabetic macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 99-104.
[4] LIANG Qianqian, YANG Tinghua, ZHAO Bojun. Application of optical coherence tomography angiography in retinal vein occlusion [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 139-142.
[5] ZHOU Xueyi, LI Yiming, WANG Meiju, ZHANG Yuanyuan, ZHANG Lizhuo. The application of 25-gauge minimally invasive vitreoretinal surgery combined with intravitreal ranibizumab injections in the treatment of proliferative diabetic retinopathy. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 87-89.
[6] . Clinical observation on the treatment of CSME and NCSME by intravitreal injection of ranibizumab. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(2): 96-98.
[7] . Clinical observation on the treatment of BRVO-ME by the combination of laser therapy with Ranibizumab intravitreal injection. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(1): 110-113.
[8] . The pathogenesis of RVO and anti-VEGF treatment for its macular edema. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(1): 123-126.
[9] ZHAO Lu, XIE Guoli, WANG Yanling. Changes of ocular hemodynamics after intravitreal ranibizumab injection in patients with wet age-related macular degeneration. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(4): 101-104.
[10] YAN Xiaoteng, FENG Jun, KANG Xinle. Intravitreal injection of conbercept for macular edema secondary to retinal vein occlusion. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(4): 105-108.
[11] XING Kai, KANG Zefeng. Clinical analysis on intravitreal injection of conbercept in the treatment of macular edema secondary to branch retinal vein occlusion. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(1): 80-82.
[12] CHAI Xuerong, ZHANG Shixi, TAO Yu, SHEN Jiaquan. Effect of intravitreal ranibizumab injection combined with trabelectomy and panretinal photocoagulation for neovascular glaucoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(3): 72-75.
[13] YAN Xiao-teng, FENG Jun, KANG Xin-le. Intravitreal triamcinolone acetonide combined with grid laser photocoagulation for patients with cystoid macular edema [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(1): 60-63.
[14] SUN Hong-yi, ZHANG Han. Changes of macular thickness under optical coherent tomography in type 2 diabetic patients with cataract after phacoemulsification surgery and IOL implantation [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(6): 72-76.
[15] ZI Yu-meng1, WANG Yu2, FAN Chuan-feng2, SHU Xiang-wen2, WU Chang-long2. Intravitreal injection of Ranibizumab for idiopathic choroidal neovascularization lesion in two courses [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(3): 63-66.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd